| 초록 |
The aim of this study was to investigate the effects of case management on serum creatinine with estimated glomerular filtration rate (eGFR) and glycemic control glycosylated hemoglobin [HbA1c] of patients Type 2 Diabetes with Chronic Kidney Disease Stage 3. This study used the quasi-experimental one-group pre-post test designed to measure the effects of the intervention using serum creatinine with estimated glomerular filtration rate (eGFR) and glycemic control glycosylated hemoglobin [HbA1c] of patients Type 2 Diabetes with Chronic Kidney Disease Stage 3. Thirty patients in Wangwiset Hospital selected by means of purposive, qualification-based sampling were given a case management program based on the National Case Management Task Force, the CMSA's Board of Directors [2009] including comprehensive health assessment, a clinical pathway developed by a multidisciplinary team, health education, a workshop to exchange the knowledge to healthy and DASH diet such as low sodium diets, avoidance of sodium-containing seasonings, reduced fat diets and high fiber diets from vegetables and fruits in community and consultation with nurse case manager of diabetes mellitus and hypertension, a home visits, follow-up telephone calls and individual learning activities serum creatinine with estimated glomerular filtration rate (eGFR) and glycemic control glycosylated hemoglobin [HbA1c] tests was collected before and after the program in the twenty-fourth weeks. Descriptive statistics and paired t-tests were used to analyze the data. After the twenty-fourth weeks, it was found that serum creatinine with estimated glomerular filtration rate (eGFR) test increased and glycemic control in glycosylated hemoglobin [HbA1c] test decreased significantly [ p-value < .05 ]. The study findings support the effect of the case management program. The findings of this study proved that the case management program is an essential component in the management of patients Type 2 Diabetes with Chronic Kidney Disease Stage 3 and should be applied for other chronic disease. |